← Open Payments lookup

MASOOD JILANI: Open Payments

NPI 1861682734 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,040 in 56 payments from 14 companies in 2025. Trend: 2023 $781 · 2024 $863 · 2025 $1,040

Food & beverage: $1,040
CompanyPaymentsAmount
ABBVIE INC.21$328
Lundbeck LLC7$147
Otsuka America Pharmaceutical, Inc.5$99
Neurocrine BioSciences, Inc.4$94
Alkermes, Inc.4$85
E.R. Squibb & Sons, L.L.C.3$63
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$55
Axsome Therapeutics, Inc.2$49
Luye Pharma (USA) Ltd.2$33
Janssen Pharmaceuticals, Inc1$21

Products named: VRAYLAR, REXULTI, INGREZZA, ARISTADA, ABILIFY ASIMTUFII, COBENFY, CAPLYTA, Auvelity.

Industry payments across TX — which companies pay providers there.